Interventional Oncology Market Size, Share, And Growth Report 2032

Interventional Oncology Market Size

The global interventional oncology market size was worth around USD 2.44 billion in 2023 and is predicted to grow to around USD 4.89 billion by 2032 with a compound annual growth rate (CAGR) of roughly 8.00% between 2024 and 2032.

The study provides historical data from 2018 to 2022 along with a forecast from 2024 to 2032 based on revenue (USD Billion). The report covers a forecast and an analysis of the interventional oncology market on a global and regional level.

Request Free Sample

Interventional Oncology Market: Overview

Interventional oncology is a field of interventional radiology that deals with the treatment and diagnosis of primary or metastatic cancers, such as kidney, liver, bone, lung, etc. As the process is minimally invasive in nature, the recovery time required is less. Interventional oncology is among the most promising and rapidly growing branch of interventional radiology. This procedure is mostly used for patients who are not eligible for chemotherapy.

According to international agencies for cancer research, in 2018, about 18.1 million new cancer patients were reported across the world. Additionally, every sixth global death is due to cancer, thus making it the second death cause globally. Escalating cancer patients, increasing elderly population, and rising cancer risk among youth due to unhealthy habits like smoking, chewing tobacco, and alcohol will drive the interventional oncology market in the future. A significant rise in disposable income, increase in cancer awareness, and high adoption of technological advancements are expected to create additional growth opportunities for the interventional oncology market in the years ahead. Improvements in the R&D process, presence of giant companies with advanced technologies and active marketing channels, ongoing developments of the healthcare infrastructure, increasing government initiatives are further stimulating the interventional oncology market growth. However, high treatment cost and adverse effects of chemotherapy drugs on patients may limit this global market.

Request Free Sample

Interventional Oncology Market: Segmentation

The interventional oncology market is fragmented on the basis of product, cancer type, procedure, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2024 to 2032.

On the basis of product, the market includes embolization devices (radioembolic and non-radioactive agents), ablation devices (cryoablation devices, radiofrequency ablation devices, microwave ablation devices, and others), and support devices (microcatheters and guidewires).

By cancer type, the interventional oncology market includes kidney, liver, lung, bone metastasis, breast, and other cancers.

Based on procedure, the market comprises thermal tumor ablation, non-thermal tumor ablation, transcatheter arterial chemoembolization, transcatheter arterial embolization, and transcatheter arterial radioembolization.

Interventional Oncology Market: Report Scope

Interventional Oncology Market: Regional Analysis

The regional segment includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

North America dominated the interventional oncology market in 2023, due to the considerably high number of cancer surgeries, especially in the U.S. In 2018, about 1.7 million new cancer cases were diagnosed and nearly around 6.5 lakh people died in the same year in the U.S. The Asia Pacific interventional oncology market is expected to record the highest CAGR in the upcoming years, as the developing economies of India, China, and South Korea and the developed economies of Japan and Australia are offering several opportunities for regional expansion to global market players.

Interventional Oncology Market: Competitive Players

Some major players involved in the interventional oncology market are:

• Boston Scientific
• Terumo Corporation
• Medtronic
• BTG
• Ethicon
• AngioDynamics
• Merit Medical Systems
• Sirtex Medical
• Eckert & Ziegler
• BEBIG
• Siemens Healthineers
• Varian Medical Systems
• HealthTronics

The Global Interventional Oncology Market is segmented as follows:

Global Interventional Oncology Market: Product Analysis

• Embolization Devices

• Radioembolic Agents
• Non-Radioactive Agents

• Ablation Devices

• Radiofrequency Ablation Devices
• Microwave Ablation Devices
• Cryoablation Devices
• Others

• Support Devices

• Guidewires
• Microcatheter

Global Interventional Oncology Market: Cancer Type Analysis

• Kidney Cancer

• Lung Cancer
• Breast Cancer
• Liver Cancer
• Bone Metastasis Cancer
• Others

Global Interventional Oncology Market: Procedure Analysis

• Thermal Tumor Ablation
• Non-Thermal Tumor Ablation
• Transcatheter Arterial Chemoembolization
• Transcatheter Arterial Radioembolization
• Transcatheter Arterial Embolization

Global Interventional Oncology Market: Regional Analysis

• North America
  • The U.S.
• Europe
  • UK
  • France
  • Germany
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
• The Middle East and Africa